PARLODEL SRO IN PARKINSONS-DISEASE - A DOUBLE-BLIND RANDOMIZED COMPARISON OF PARLODEL STANDARD AND PARLODEL SRO

ENH JANSEN*, A STAALSCHREINEMACHERS, JJ VANDERSANDE, JA HAAS, JPWF LAKKE

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    1 Citation (Scopus)

    Abstract

    In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic formulation in 34 patients with Parkinson's disease who received optimal levodopa therapy. The results suggest that Parlodel SRO was equally efficacious as Parlodel standard, but Parlodel SRO is better tolerated.

    Original languageEnglish
    Pages (from-to)318-320
    Number of pages3
    JournalEuropean Neurology
    Volume32
    Issue number6
    Publication statusPublished - 1992

    Keywords

    • PARKINSONS DISEASE
    • PARLODEL
    • LEVODOPA THERAPY
    • FOLLOW-UP
    • BROMOCRIPTINE
    • THERAPY
    • LEVODOPA

    Cite this